CCL2 and systemic sclerosis: In this regard, it has been shown in SSc patients that CCL2 induces infiltrating CD4+ T cells to differentiate into T-helper 2 cells, which release higher amounts of IL-4 and stimulate fibroblasts to produce excess ECM [54].